G-protein coupled receptors (GPCRs), ion channels, and transporters are areas of intense basic research and are proven drug targets. However, there remains a need for new tools to develop a better understanding of the roles of these proteins in biological systems and to pave the way for discovery of therapeutic agents. Although ligand discovery has been performed on these proteins in pharmaceutical companies, their retail product interests often preclude, or greatly delay, the publication of research findings or consider only one of the many possible modes of target/small molecule interaction. Despite intense interest of multiple academic and industry labs, small molecules ligands do not exist for the vast majority of GPCRs, ion channels, and transporters. The research community, supported by the Molecular Libraries and Screening Centers Network (MLSCN) initiative, has an excellent opportunity to develop novel tools to aid in understanding these proteins. Thus, we propose to develop a MLSCN screening center focused on the generation of chemical tools for the study of G-protein coupled receptors, ion channels, and transporters. We will perform cell-based functional HTS for these proteins using industry-standard instrumentation and screening methods. We will further enhance our ability to rapidly discover and characterize novel tools for these targets and the signaling pathways/physiological systems of which they are a part by using new technologies that will allow more physiologically-relevant interrogation of interactions between these proteins and their partners. We will develop the expertise, technologies, and methods to understand and improve the properties of small molecules discovered through HTS to produce tools to support basic and translational research. Vanderbilt University is well suited to support an MLSCN center due to its combination of basic and industrial research expertise in the proposed target areas, its dedication to translational and chemical biology, and its tradition of excellence in the establishing and maintaining highly-collaborative laboratories and core facilities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
3U54MH074427-03S2
Application #
7691076
Study Section
Special Emphasis Panel (ZMH1-ERB-Y (02))
Program Officer
Brady, Linda S
Project Start
2005-07-01
Project End
2010-06-30
Budget Start
2008-09-30
Budget End
2010-06-30
Support Year
3
Fiscal Year
2008
Total Cost
$767,500
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Jalan-Sakrikar, Nidhi; Field, Julie R; Klar, Rebecca et al. (2014) Identification of positive allosteric modulators VU0155094 (ML397) and VU0422288 (ML396) reveals new insights into the biology of metabotropic glutamate receptor 7. ACS Chem Neurosci 5:1221-37
Kaufmann, Kristian; Romaine, Ian; Days, Emily et al. (2013) ML297 (VU0456810), the first potent and selective activator of the GIRK potassium channel, displays antiepileptic properties in mice. ACS Chem Neurosci 4:1278-86
Potet, Franck; Lorinc, Amanda N; Chaigne, Sebastien et al. (2012) Identification and characterization of a compound that protects cardiac tissue from human Ether-à-go-go-related gene (hERG)-related drug-induced arrhythmias. J Biol Chem 287:39613-25
Bhave, Gautam; Chauder, Brian A; Liu, Wen et al. (2011) Development of a selective small-molecule inhibitor of Kir1.1, the renal outer medullary potassium channel. Mol Pharmacol 79:42-50
Miller, Nicole R; Daniels, R Nathan; Lee, David et al. (2010) Synthesis and SAR of N-(4-(4-alklylpiperazin-1-yl)phenyl)benzamides as muscarinic acetylcholine receptor subtype 1 (M1) anatgonists. Bioorg Med Chem Lett 20:2174-7
Sheffler, Douglas J; Williams, Richard; Bridges, Thomas M et al. (2009) A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning. Mol Pharmacol 76:356-68
Lewis, L Michelle; Bhave, Gautam; Chauder, Brian A et al. (2009) High-throughput screening reveals a small-molecule inhibitor of the renal outer medullary potassium channel and Kir7.1. Mol Pharmacol 76:1094-103
Delpire, Eric; Days, Emily; Lewis, L Michelle et al. (2009) Small-molecule screen identifies inhibitors of the neuronal K-Cl cotransporter KCC2. Proc Natl Acad Sci U S A 106:5383-8
Lewis, L Michelle; Sheffler, Douglas; Williams, Richard et al. (2008) Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists. Bioorg Med Chem Lett 18:885-90